ロード中...
Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives
Triple-negative breast cancer (TNBC) is characterized by the lack of clinically significant levels of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Owing to the aggressive nature and the emergence of resistance to chemotherapeutic drugs, pat...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8170306/ https://ncbi.nlm.nih.gov/pubmed/34094935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.648139 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|